Paper · 4015380
Pancreatic cancer. Adjuvant combined radiation and chemotherapy following curative resection.
Kalser MH and 1 other. Arch Surg, 1985. Cited by 1,170 papers, by iCite.
11 sourcespapers-2026-11-12-0.1.0
Cite this record
ConductScience Library. Pancreatic cancer. Adjuvant combined radiation and chemotherapy following curative resection. Papers, record 4015380. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/4015380
On this page
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics13
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Adenocarcinoma | Major topic |
| Pancreatic Neoplasms | Major topic |
| Aged | |
| Combined Modality Therapy | |
| Female | |
| Fluorouracil | |
| Humans | |
| Leukopenia | |
| Male | |
| Middle Aged | |
| Pancreatectomy | |
| Prognosis | |
| Radiotherapy Dosage |
Source PubMed
Grants3
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by | Source |
|---|---|---|---|---|---|
| 1-CM-43795 | NCI NIH HHS | United States | N01CM043795 | PubMed and NIH | NIH RePORTER |
| 1-CM-43796 | NCI NIH HHS | United States | N01CM043796 | PubMed and NIH | NIH RePORTER |
| 1-CM-43797 | NCI NIH HHS | United States | N01CM043797 | PubMed and NIH | NIH RePORTER |
Trials5
The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.
| Trial | Title | The trial lists it as | Named in the paper's record | Source |
|---|---|---|---|---|
| NCT01553019 | Postoperative Proton Radiotherapy With Chemo for Pancreatic Cancer | Background | ClinicalTrials.gov | |
| NCT02599662 | Intraoperative Radiation Therapy for Resectable Pancreas Cancer | Background | ClinicalTrials.gov | |
| NCT03167112 | A Study of Administering FOLFIRINOX Before Surgery For Potentially Curable Pancreatic Cancer | Results | ClinicalTrials.gov | |
| NCT03959150 | Metronomic Chemotherapy With Capecitabine for Pancreatic Cancer | Background | ClinicalTrials.gov | |
| NCT04106856 | Losartan and Hypofractionated Rx After Chemo for Tx of Borderline Resectable or Locally Advanced Pancreatic Cancer | Background | ClinicalTrials.gov |
Comments and corrections0
PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.
None in this release.
References0
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
None in this release.
Cited by415
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 1,170 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42,738,277 | Adjuvant Therapy in Pancreatic Ductal Adenocarcinoma-Past, Present, and Future. | Cancers (Basel) | 2026 | https://conductscience.org/library/papers/42738277 | PubMed |
| 42,592,360 | Exploring the role of immunotherapy and radiotherapy in the adjuvant landscape of resected pancreatic cancer. | Transl Gastroenterol Hepatol | 2026 | https://conductscience.org/library/papers/42592360 | PubMed |
| 42,380,817 | Comparative efficacy of postoperative adjuvant chemoradiotherapy versus no chemoradiotherapy in the treatment of pancreatic adenocarcinoma. | BMC Cancer | 2026 | https://conductscience.org/library/papers/42380817 | PubMed |
| 42,352,447 | Chemotherapy Completion as a Quality Metric in Resected Pancreatic Ductal Adenocarcinoma. | Cancers (Basel) | 2026 | https://conductscience.org/library/papers/42352447 | PubMed |
| 42,169,941 | Neoadjuvant radiotherapy after chemotherapy does not improve surgical or survival outcomes in borderline resectable pancreatic cancer. | J Gastrointest Oncol | 2026 | https://conductscience.org/library/papers/42169941 | PubMed |
| 42,129,843 | Adjuvant stereotactic pancreatic radiotherapy (SPARTA trial): interim safety analysis of an ongoing phase II single center prospective study. | Radiat Oncol | 2026 | https://conductscience.org/library/papers/42129843 | PubMed |
| 41,514,607 | Personalizing Treatment for Pancreatic Ductal Adenocarcinoma: The Emerging Role of Minimal Residual Disease in Perioperative Decision-Making. | Cancers (Basel) | 2025 | https://conductscience.org/library/papers/41514607 | PubMed |
| 41,365,129 | Radiotherapy in the management of PDAC, from past to present. | Transl Oncol | 2026 | https://conductscience.org/library/papers/41365129 | PubMed |
| 41,117,833 | Adjuvant treatment after surgical resection of pancreatic cancer. | Surg Today | 2026 | https://conductscience.org/library/papers/41117833 | PubMed |
| 40,662,364 | Evolving concepts in adjuvant/neoadjuvant therapy for resectable pancreas cancer. | J Clin Invest | 2025 | https://conductscience.org/library/papers/40662364 | PubMed |
1 to 10 of 415
See all 415 cited byGenes0
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
None in this release.
Drugs4
The drugs whose trials, in the Pipelines release, list the paper.
| Drug | ChEMBL ID | The trials list it as | Trials | In Drugs and targets | Source |
|---|---|---|---|---|---|
| LEUCOVORIN CALCIUM | CHEMBL1201138 | Results | 1 | https://conductscience.org/library/drugs/CHEMBL1201138 | ChEMBL |
| FLUOROURACIL | CHEMBL185 | Results | 1 | https://conductscience.org/library/drugs/CHEMBL185 | ChEMBL |
| OXALIPLATIN | CHEMBL414804 | Results | 1 | https://conductscience.org/library/drugs/CHEMBL414804 | ChEMBL |
| IRINOTECAN | CHEMBL481 | Results | 1 | https://conductscience.org/library/drugs/CHEMBL481 | ChEMBL |
Data0
The data bank entries PubMed's record names. Trial numbers are under Trials.
None in this release.
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/4015380
GET https://conductscience.org/api/papers/v1/4015380/cited_by?page=2